Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.58 CAD | -1.86% | 0.00% | -52.84% |
May. 14 | Transcript : Aptose Biosciences Inc., Q1 2024 Earnings Call, May 14, 2024 | |
May. 14 | Aptose Biosciences Q1 Net Loss Falls, on Lower Expenses | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-52.84% | 19.25M | |
+53.52% | 63.85B | |
-1.95% | 41.83B | |
+39.84% | 40.47B | |
-10.22% | 27.17B | |
+14.16% | 26.52B | |
-20.35% | 18.69B | |
+3.02% | 12.73B | |
+22.17% | 12.11B | |
+29.01% | 12.07B |
- Stock Market
- Equities
- APS Stock
- News Aptose Biosciences Inc.
- RBC Capital Keeps Outperform/Speculative Risk, US$7 TP on Aptose Biosciences After Q4 Results